Huzi Xu

机构：South China Normal University, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0003-0267-2014

发表论文 22 篇 · 总被引 1059 次 · h-index 13

代表论文

• The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease (2021 · Cell Metabolism · 被引 280)
• XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injury (2020 · Cell Death and Disease · 被引 229)
• Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation (2017 · Oncotarget · 被引 118)
• The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease (2021 · Cell Metabolism · 被引 60)
• Blocking connexin 43 and its promotion of ATP release from renal tubular epithelial cells ameliorates renal fibrosis (2022 · Cell Death and Disease · 被引 59)
• Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways (2019 · Journal of Translational Medicine · 被引 42)